In the race to forge the next Keytruda from PD-(L)1xVEGF bispecific antibodies, Pfizer and the BioNTech-Bristol Myers Squibb alliance are split on how to position overall survival—the gold-standard ...

The Professor reviews the Redodo 200Ah Plus LiFePO4 drop in lead acid replacement battery for rv and off grid living with 2560wh of power and 200 amp BMS. discount codes on solar panels - generators - ...

Thousands, mainly those associated with the Trinamool Congress, became self-proclaimed activists of the BJP's student outfit ...

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with ...

Bristol Myers Squibb may be leading the way when it comes to pursuing cereblon E3 ligase modulator (CELMoD) drugs, but today, the pharma is standing tall.  | Bristol Myers Squibb may have gone big in ...

BMS will roll out Claude to over 30,000 employees, targeting three main areas for near-term impact.

First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encouraging efficacy in combination with chemotherapy in first-line non-small cell lung cancer across PD-L1 ...

Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with carfilzomib and dexamethasone (MeziKd ...

Just two weeks after submitting its application for a state tax incentive, Bristol Myers Squibb Co. (NYSE: BMY) has received ...

BMS urges Odisha CM to halt layoffs of thousands of contractual workers, warning of intensified protests if demands for reinstatement and job security aren't met.

Bristol Myers Squibb has high hopes for its celmod programme for blood cancers, and a phase 3 readout – for mezigdomide in multiple myeloma – has delivered the goods. The cereblon E3 ligase modulator, ...

After trying lots of different cuts of American Wagyu from lots of different producers, I’ve been burned many times — and now I’ve got beef (get it?) with it. I’ve spent a lot of time in Japan, both ...